Wordt geladen...
Review of the current targeted therapies for non-small-cell lung cancer
The last decade has witnessed the development of oncogene-directed targeted therapies that have significantly changed the treatment of non-small-cell lung cancer (NSCLC). In this paper we review the data demonstrating efficacy of gefitinib, erlotinib, and afatinib, which target the epidermal growth...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Baishideng Publishing Group Inc
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4129523/ https://ncbi.nlm.nih.gov/pubmed/25302162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v5.i4.576 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|